講演・口頭発表等 - 清水　正樹

1. Hiroyuki Wakiguchi, Kunio Hashimoto, Masato Yashiro, Kenichi Nishimura, Takasuke Ebato, Keiji Akamine, Yoji Uejima, Tomomi Sato, Kazutaka Ouchi, Mao Mizuta, Yuko Sugita, Natsumi Inoue, Yoshiro Kitagawa, Nami Okamoto, Yasuo Nakagishi, Masaki Shimizu. THE EDUCATIONAL ROLE OF THE TEAM OF MIDDLE-STANDING PEDIATRIC RHEUMATOLOGISTS ALLIANCE (TEMPRA) FOR THE CONTINUOUS PROFESSIONAL DEVELOPMENT OF PEDIATRIC RHEUMATOLOGISTS IN JAPAN. the 32nd Paediatric Rheumatology European Society Congress (PReS 2025 Congress) 2025.09.19 Helsinki, Finland

2. Masaki Shimizu, Maho Hatano, Shuya Kaneko, Futaba Miyaoka, Asami Shimbo, Hitoshi Irabu, Yuko Akutsu, Yuko Hayashi, Masaaki Mori. Distinct Roles of Serum Free and Total Interleukin 18 Level As s Biomarker For Still’s Disease and Macrophage Activation Syndrome. the 32nd Paediatric Rheumatology European Society Congress (PReS 2025 Congress) 2025.09.19 Helsinki, Finland

3. Sebastian J. Vastert, Jordi Antón, Pierre Quartier, Bruno Fautrel, Paul Brogan, Edward M Behrens, Melissa Elder, Francesca Minoia, Pavla Dolezalova, Robert Biesen, Masaki Shimizu, Uwe Ullmann, Adnan Mahmood, Andrew Danquah, Elena Burillo, Marco Petrimpol, Steve Mallett, Brian D. Jamieson, Alexi Grom, Fabrizio De Benedetti. CHANGES IN PHARMACODYNAMIC MARKERS (PD) IN RESPONSE TO EMAPALUMAB IN CHILDREN AND ADULTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) IN STILL’S DISEASE: RESULTS FROM A POOLED ANALYSIS OF TWO PROSPECTIVE TRIALS. the 32nd Paediatric Rheumatology European Society Congress (PReS 2025 Congress) 2025.09.19 Helsinki, Finland

4. Francesco Baldo, Greta Rogani, Claudia Bracaglia, Dirk Foell, Marco Gattorno, Marija Jelusic, Jordi Anton, Paul Brogan, Scott Canna, Randy Cron, Fabrizio De Benedetti, Alexei Grom, Merav Heshin Bekenstein, AnnaCarin Horne, Raju Khubchandani, Mao Mizuta, Seza Ozen, Pierre Quartier, Angelo Ravelli, Masaki Shimizu, Grant Schulert, Rasmhi Sinha, Christiaan Scott, Nicolino Ruperto, Joost Swart, Bruno Fautrel, Sebastiaan Vastert, Francesca Minoia. FACTORS DRIVING THERAPEUTIC DECISION-MAKING IN STILL’S DISEASE: WHEN TO START AND WHEN TO STOP? DATA FROM THE METAPHOR PROJECT WORLDWIDE SURVEY. the 32nd Paediatric Rheumatology European Society Congress (PReS 2025 Congress) 2025.09.19 Helsinki, Finland

5. Kenichi Nishimura, Mao Mizuta, Seira Hattori, Asami Ohara, Hitoshi Irabu, Yuko Hayashi, Yukari Aida, Maho Shimizu, Shinji Kawabe, Keiji Akamine, Utako Kaneko, Takasuke Ebato, Yuko Sugita, Kunio Hashimoto, Naohiro Itoh, Ryuhei Yasuoka, Hiroyuki Wakiguchi, Junko Yasumura, Yuichi Yamasaki, Yasuo Nakagishi, Hiroaki Umebayashi, Nami Okamoto, Naomi Iwata, Takahiro Yasumi, Masaki Shimizu. CLINICAL AND LABORATORY INDICATORS FOR IMPROVEMENT AND TAPERING OF TREATMENT IN MACROPHAGE ACTIVATION SYNDROME ASSOCIATED WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY. the 32nd Paediatric Rheumatology European Society Congress (PReS 2025 Congress) 2025.09.18 Helsinki, Finland

6. M. Hatano, S. Kaneko, F. Miyaoka, A. Shimbo, H. Irabu, Y. Akutsu, Y. Hayashi, M. Shimizu, M. Mori. VARIATIONS OF LYMPHOCYTE SUBPOPULATIONS IN MACROPHAGE ACTIVATION SYNDROME ASSOCIATED STILL’S DISEASE: POSSIBLE ROLE OF B CELLS, NK CELLS, AND CD38+HLA-DR+CD8+ T CELLS AS A BIOMARKER FOR THE DIAGNOSIS OF MACROPHAGE ACTIVATION SYNDROME. the 32nd Paediatric Rheumatology European Society Congress (PReS 2025 Congress) 2025.09.18 Helsinki, Finland

7. Mao Mizuta, Kenichi Nishimura, Seira Hattori, Asami Ohara, Yuko Hayashi, Hitoshi Irabu, Yukari Aida, Maho Shimizu, Shinji Kawabe, Keiji Akamine, Utako Kaneko, Takasuke Ebato, Yuko Sugita, Kunio Hashimoto, Naohiro Itoh, Ryuhei Yasuoka, Hiroyuki Wakiguchi, Junko Yasumura, Yuichi Yamasaki, Yasuo Nakagishi, Hiroaki Umebayashi, Nami Okamoto, Naomi Iwata, Takahiro Yasumi, Masaki Shimizu. CLINICAL AND LABORATORY FEATURES OF MACROPHAGE ACTIVATION SYNDROME ASSOCIATED WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS RECEIVING TOCILIZUMAB AND CANAKINUMAB. the 32nd Paediatric Rheumatology European Society Congress (PReS 2025 Congress)　 2025.09.18 Helsinki, Finland

8. Francesco Baldo, Greta Rogani, Claudia Bracaglia, Dirk Foell, Marco Gattorno, Marija Jelusic, Jordi Anton, Paul Brogan, Scott Canna, Randy Cron, Fabrizio De Benedetti, Alexei Grom, Merav Heshin Bekenstein, AnnaCarin Horne, Raju Khubchandani, Mao Mizuta, Seza Ozen, Pierre Quartier, Angelo Ravelli, Masaki Shimizu, Grant Schulert, Rasmhi Sinha, Christiaan Scott, Nicolino Ruperto, Joost Swart, Bruno Fautrel, Sebastiaan Vastert, Francesca Minoia. THERAPEUTIC STRATEGIES IN NEWLY DIAGNOSED STILL’S DISEASE: REAL-LIFE CLINICIANS’ CHOICES FROM THE METAPHOR PROJECT WORLDWIDE SURVEY. the 32nd Paediatric Rheumatology European Society Congress (PReS 2025 Congress) 2025.09.18 Helsinki, Finland

9. Greta Rogani, Francesco Baldo, Claudia Bracaglia, Dirk Foell, Marco Gattorno, Marija Jelusic, Jordi Anton, Paul Brogan, Scott W. Canna, Randy Q. Cron, Fabrizio De Benedetti, Alexei Grom, Merav Heshin Bekenstein, AnnaCarin Horne, Raju Khubchandani, Mao Mizuta, Seza Ozen, Pierre Quartier Dit Maire, Angelo Ravelli, Masaki Shimizu, Grant Schulert, Christiaan Scott, Rashmi Sihna, Nicolino Ruperto, Joost Swart, Bruno Fautrel, Sebastiaan Vastert, Francesca Minoia. REAL-LIFE TREATMENT STRATEGIES FOR REFRACTORY STILL’S DISEASE: RESULTS FROM A WORLDWIDE SURVEY, THE METAPHOR PROJECT. the 32nd Paediatric Rheumatology European Society Congress (PReS 2025 Congress) 2025.09.18 Helsinki, Finland

10. Shuya Kaneko, Asami Shimbo, Maho Hatano, Hitoshi Irabu, Yuko Akutsu, Yuko Hayashi, Shuhei Fujita, Keiji Akamine, Kenji Furuno, Junya Fujimura, Naomi Iwata, Koji Yokoyama, Masaaki Mori, Masatoshi Takagi, Masaki Shimizu. Distinct Cytokine Profiles in Kawasaki Disease and MIS-C: Identification of Biomarkers and Predictors of Coronary Artery Lesion Development. The 27th Asia-Pacific League of Associations for Rheumatology Congress (APLAR2025) 2025.09.06 福岡

11. Masaki Shimizu. Challenges in Diagnosis and Early Management. the 27th Asia Pacific League of Associations for Rheumatology （APLAR2025） 2025.09.05 Fukuoka, Japan

12. Yuko Hayashi, Hitoshi Irabu, Asami Ohara, Aki Nakamura, Hidehiko Narazaki, Yasuo Nakagishi, Daisuke Fukuhara, Hiroyuki Ishida, Miwa Goto, Kunio Hashimoto, Ryuhei Yasuoka, Tomo Nozawa, Yuichi Yamasaki, Naomi Iwata, Hiroaki Umebayashi, Masaaki Mori, Masaki Shimizu. Clinical Characteristics of Childhood-Onset SLE and Validation of the 2019 ACR/EULAR Classification Criteria for SLE in Japanese patients. The 27th Asia-Pacific League of Associations for Rheumatology Congress (APLAR2025) 2025.09.05 福岡

13. Masaki Shimizu. hemophagocytic lymphohistiocytosis and macrophage activation syndrome. the 12th International Pediatric Rheumatology Forum 2025.08.16 Beijing, China

14. Masaki Shimizu. Role of inflammatory cytokines and cytokine-targeted therapy in systemic JIA and MAS. KCR2025-KCPCI Joint Symposium 2025.05.17 Seoul, Korea

15. Masaki Shimizu. Clinical significance of serum cytokine profiles and cytokine-targeted therapy in systemic juvenile idiopathic arthritis and macrophage activation syndrome. The 11th International Forum of Pediatric Rheumatology and Immunology 2024.12.20 Beijing, China

16. Masaki Shimizu. Clinical significance of serum IL-18 levels for diagnosis & monitoring of disease activity in SJIA & MAS. NextGen Therapies in SJIA, Still’s & MAS 2024.11.13 Washington DC, USA

17. Kaneko S; Shimbo A; Hatano M; Irabu H; Shimizu M. Clinical significance of serum cytokine profiling for differentiation of underlying diseases of cytokine storm syndrome. APLAR2024 2024.08.22 Singapore, Singapore

18. Masaki Shmizu, Shuya Kaneko, Asami Shimbo, Maho Hatano, Futaba Miyaoka, Yuko Hayashi, Hitoshi Irabu, Yuko Akutsu, Keiji Akamine, Masaaki Mori. Successful treatment with anifrolumab for refractory cutaneous lesions in pediatric systemic lupus erythematosus. APLAR2024 2024.08.22 Singapore, Singapore

19. Yuko Hayashi, Maho Hatano, Shuya Kaneko, Asami Shimbo, Hitoshi Irabu, Yuko Akutsu, Masaki Shimizu, Masaaki Mori. Clinical outcomes after SARS-CoV-2 infection and vaccination in patients with pediatric rheumatic diseases. 26th Asia-Pacific League of Associations for Rheumatology Congress 2024.08.21 シンガポール

20. Shuya Kaneko, Maho Hatano, Asami Shimbo, Hitoshi Irabu, Masaki Shimizu, Tomohiro Morio. Pathogenic role of inflammasome activation and interleukin-1β overproductionin Kawasaki disease. The 3rd International Symposium of Clinical Immunology 2024.05.17 Hakodate, Japan